Adam Laponis, Chief Financial Officer at Twist Bioscience Corp (TWST), sold 4,000 shares at $60.00 ($240K) on 2026-04-17, disclosed to the SEC on 2026-04-21.
Scheduled sale ($240k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TWST | SELL | 2026-08-25 | $273K | — | Filing → |
| TWST | SELL | 2026-07-13 | $226K | — | Filing → |
| TWST | SELL | 2026-06-02 | $280K | — | Filing → |